Azatadine
RESPIRATORY SYSTEM
Also known as: azatadine maleate, azatidine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Azatadine is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1977. DrugCentral lists 2 molecular targets, including Hrh1 and HRH1. Recorded indications include Allergic conjunctivitis, Allergic rhinitis, Anaphylaxis Adjunct and Common cold.
- Approval status: ofm (first approved 1977 by the FDA).
- Molecular targets: Hrh1 and HRH1 (2 listed in DrugCentral).
- Indications: Allergic conjunctivitis, Allergic rhinitis, Anaphylaxis Adjunct, Common cold and Dermatographic urticaria and others.
- ATC code: R06AX09 (Other antihistamines for systemic use).
- Molecular formula: C20H22N2; molecular weight 290.41 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (12)
- Allergic conjunctivitis
- Allergic rhinitis
- Anaphylaxis Adjunct
- Common cold
- Dermatographic urticaria
- Itching of skin
- Nasal congestion
- Nasal discharge
- Seasonal allergic rhinitis
- Sneezing
- Urticaria
- Vasomotor rhinitis
Contraindications (8)
- Angle-closure glaucoma
- Benign prostatic hyperplasia
- Coronary arteriosclerosis
- Diabetes mellitus
- Hypertensive disorder
- Hypertensive urgency
- Hyperthyroidism
- Retention of urine
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Histamine H1 receptor | Hrh1 | unknown | Ki 8.41 |
| Histamine H1 receptor | HRH1 | antagonist | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1977-03-29 | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
R06AX09 | RESPIRATORY SYSTEM › ANTIHISTAMINES FOR SYSTEMIC USE › ANTIHISTAMINES FOR SYSTEMIC USE › Other antihistamines for systemic use |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Azatadine is on its molecule page.
| Molecular formula | C20H22N2 |
|---|---|
| Molecular weight | 290.41 g/mol |
| CAS number | 3964-81-6 |
| InChIKey | SEBMTIQKRHYNIT-UHFFFAOYSA-N |
| PubChem CID | 19861 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Azatadine used for?
DrugCentral lists the following indications for Azatadine: Allergic conjunctivitis, Allergic rhinitis, Anaphylaxis Adjunct, Common cold, Dermatographic urticaria, Itching of skin, Nasal congestion and Nasal discharge and others.
How does Azatadine work?
Its molecular targets in DrugCentral include Hrh1 and HRH1 (antagonist).
When was Azatadine first approved?
Azatadine was first approved by the FDA in 1977.
What is the chemical formula of Azatadine?
Azatadine has the molecular formula C20H22N2 and a molecular weight of 290.41 g/mol.
Browse: all drugs starting with A · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 268 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL3544908 — compound record and bioactivity
- PubChem CID 19861 — chemical identifiers
- DrugBank DB00719 — drug record
- FDA UNII 94Z39NID6C — substance identity
- DailyMed: FDA labels for Azatadine — current prescribing information (label search)
- UniProt P35367 (HRH1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.